Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C10H16N5O12P3 |
Molecular Weight | 491.1816 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 3 / 3 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
NC1=NC=NC2=C1N=CN2[C@@H]3O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)C[C@H]3O
InChI
InChIKey=NLIHPCYXRYQPSD-BAJZRUMYSA-N
InChI=1S/C10H16N5O12P3/c11-8-7-9(13-3-12-8)15(4-14-7)10-6(16)1-5(25-10)2-24-29(20,21)27-30(22,23)26-28(17,18)19/h3-6,10,16H,1-2H2,(H,20,21)(H,22,23)(H2,11,12,13)(H2,17,18,19)/t5-,6+,10+/m0/s1
Molecular Formula | C10H16N5O12P3 |
Molecular Weight | 491.1816 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 3 / 3 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
Effect of hydroxyurea and dideoxyinosine on intracellular 3'-deoxyadenosine-5'-triphosphate concentrations in HIV-infected patients. | 2007 Nov |
|
Hepatitis C virus helicase/NTPase: an efficient expression system and new inhibitors. | 2008 Jun |
|
Cordycepin interferes with 3' end formation in yeast independently of its potential to terminate RNA chain elongation. | 2009 May |
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 01:59:00 GMT 2023
by
admin
on
Sat Dec 16 01:59:00 GMT 2023
|
Record UNII |
59P84ZU54H
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C1556
Created by
admin on Sat Dec 16 01:59:01 GMT 2023 , Edited by admin on Sat Dec 16 01:59:01 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
DB01860
Created by
admin on Sat Dec 16 01:59:01 GMT 2023 , Edited by admin on Sat Dec 16 01:59:01 GMT 2023
|
PRIMARY | |||
|
52316
Created by
admin on Sat Dec 16 01:59:01 GMT 2023 , Edited by admin on Sat Dec 16 01:59:01 GMT 2023
|
PRIMARY | |||
|
C967
Created by
admin on Sat Dec 16 01:59:01 GMT 2023 , Edited by admin on Sat Dec 16 01:59:01 GMT 2023
|
PRIMARY | |||
|
m3784
Created by
admin on Sat Dec 16 01:59:01 GMT 2023 , Edited by admin on Sat Dec 16 01:59:01 GMT 2023
|
PRIMARY | Merck Index | ||
|
DTXSID501014467
Created by
admin on Sat Dec 16 01:59:01 GMT 2023 , Edited by admin on Sat Dec 16 01:59:01 GMT 2023
|
PRIMARY | |||
|
65562
Created by
admin on Sat Dec 16 01:59:01 GMT 2023 , Edited by admin on Sat Dec 16 01:59:01 GMT 2023
|
PRIMARY | |||
|
73-04-1
Created by
admin on Sat Dec 16 01:59:01 GMT 2023 , Edited by admin on Sat Dec 16 01:59:01 GMT 2023
|
PRIMARY | |||
|
59P84ZU54H
Created by
admin on Sat Dec 16 01:59:01 GMT 2023 , Edited by admin on Sat Dec 16 01:59:01 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TARGET -> INHIBITOR |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> METABOLITE ACTIVE |
|
||
|
PRODRUG -> METABOLITE ACTIVE |
|
||
|
PRODRUG -> METABOLITE ACTIVE |
|